|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Arrhythmia | |||||
| Heart Arrest | |||||
| Heart Diseases | |||||
| Myocardial Infarction | |||||
| Ventricular Fibrillation | |||||
| Death, Sudden, Cardiac | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Arrhythmias, Cardiac | |||||
| Death, Sudden | |||||
| Infarction | |||||
| 3 | More general conditions related to this trial | ||||
| Cardiovascular Diseases | |||||
| Death | |||||
| Ischemia | |||||
| Myocardial Ischemia | |||||
| Necrosis | |||||
| Pathologic Processes | |||||
| Vascular Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| defibrillator | |||||
| 5 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||